SkinBioTherapeutics (SBTX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

16.63p
   
  • Change Today:
    -0.25p
  • 52 Week High: 26.10
  • 52 Week Low: 8.50
  • Currency: UK Pounds
  • Shares Issued: 234.07m
  • Volume: 397,954
  • Market Cap: £38.91m
  • Beta: 0.01

SBTX Overview

SkinBioTherapeutics is a life science company focused on skin health. The Company’s proprietary platform technology, SkinBiotix®, is based upon discoveries made by CSO Dr. Catherine O’Neill and Professor Andrew McBain at The University of Manchester.

Key Personnel

CEO: Stuart Ashman
CFO: Manprit Singh Randhawa
Executive Director: Simon Hewitson
Group Finance Director: Emily Bertram
Independent Non-Executive Director: Catherine Denise Prescott
Non-Executive Chairman: Martin Braddock Hunt
Non-Executive Dir: Danielle Bekker

Contact Details

Address: The Core, Bath Lane, Newcastle Helix, Newcastle upon Tyne, United Kingdom, NE4 5TF
Phone: +44 191 495 7325
Website: http://www.skinbiotherapeutics.com

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE AIM All-Share
ISIN: GB00BF33H870

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

SBTX Market Data

Currency UK Pounds
Share Price 16.63p
Change Today -0.25p
% Change -1.48 %
52 Week High 26.10
52 Week Low 8.50
Volume 397,954
Shares Issued 234.07m
Market Cap £38.91m
Beta 0.01

SBTX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
71.04% below the market average71.04% below the market average71.04% below the market average71.04% below the market average71.04% below the market average
86.96% below the sector average86.96% below the sector average86.96% below the sector average86.96% below the sector average86.96% below the sector average
Price Trend
52.47% above the market average52.47% above the market average52.47% above the market average52.47% above the market average52.47% above the market average
73.91% above the sector average73.91% above the sector average73.91% above the sector average73.91% above the sector average73.91% above the sector average
Income Not Available
Growth
48.90% above the market average48.90% above the market average48.90% above the market average48.90% above the market average48.90% above the market average
67.74% above the sector average67.74% above the sector average67.74% above the sector average67.74% above the sector average67.74% above the sector average

SBTX Dividends

No dividends found

Trades for 19-Jun-2025

Time Volume / Share Price
16:05 1,993 @ 16.50p
16:01 25,000 @ 16.69p
15:48 579 @ 16.70p
15:48 10,000 @ 16.61p
13:28 15,527 @ 16.55p

SBTX Key Personnel

CEO Stuart Ashman
CFO Manprit Singh Randhawa

Top of Page